MARY-ANN BOLTE: Open Payments
NPI 1407954472 · BELLEVUE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 16 payments from 6 companies in 2025. Trend: 2023 $662 · 2024 $636 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $186 |
| E.R. Squibb & Sons, L.L.C. | 5 | $175 |
| Axsome Therapeutics, Inc. | 2 | $153 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Alkermes, Inc. | 1 | $28 |
| Tris Pharma Inc | 1 | $14 |
Products named: CAPLYTA, COBENFY, Auvelity, TRINTELLIX, LYBALVI, Dyanavel XR.
Industry payments across WA — which companies pay providers there.
